POAI Logo 011319 (002).jpg
Predictive Oncology Inc. Announces Newest Board Member
April 27, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology Inc. Announces New CEO
March 23, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, March 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Reports Year End 2020 Financial Results, Provides Business Update
March 15, 2021 17:15 ET | Predictive Oncology Inc.
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) – Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”)...
POAI Logo 011319 (002).jpg
Predictive Oncology’s, Skyline Medical Division, Developing Generation 3 Direct-to-Drain Automated Fluid Waste Management System
March 08, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, March 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer
February 24, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market
February 23, 2021 17:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces $17.6 Million Private Placement Priced At-the-Market
February 18, 2021 09:00 ET | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
POAI Logo 011319 (002).jpg
Two Top Researchers find Breakthrough Discoveries using Predictive Oncology’s Wholly Owned Subsidiary, TumorGenesis’s Technology
February 17, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces Closing of $7.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
February 16, 2021 17:00 ET | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces $7.4 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
February 11, 2021 00:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...